ACEI ARB

Related by string. * ACEIs : ACEI / arbs . ARBS . ARBs . Arbed . arb . Arbing . Arber . Arb : angiotensin receptor blockers ARBs . Sherri Childers Arb . LME Shanghai arb . Spokeswoman Sherrie Childers Arb . ARB Apex Bank . Childers Arb . angiotensin receptor blocker ARB . OpenGL ARB . ARB No.# . Arbitron ARB . Arber Zwiesel Germany . Luxembourg Arbed . Merger Arb ETF . NYSE ARB . Mark Arber . Jonathan Arber * *

Related by context. Frequent words. (Click for all words.) 61 thromboembolic events 60 myocardial infarction stroke 59 stable angina 59 enalapril 59 unfractionated heparin 59 lipid lowering drugs 59 left ventricular dysfunction 59 antithrombotic 58 DMARD 58 abciximab 58 vertebral fracture 58 discontinuations due 58 virologic failure 58 active comparator 57 thromboembolism 57 #mg dose [003] 57 Secondary endpoints included 57 dacarbazine 57 peginterferon alfa 2b 57 tamsulosin 57 mitoxantrone 57 QT prolongation 57 ramipril 57 angina pectoris 56 hepatotoxicity 56 candesartan 56 FOLFIRI 56 HbA1c levels 56 renal insufficiency 56 plus methotrexate 56 hypomagnesemia 56 Secondary endpoints include 56 amlodipine 56 NRTI 56 severe hypoglycemia 56 confidence interval #.#-#.# 56 prespecified 56 serum phosphorus 55 tocilizumab 55 placebo p = 55 myocardial infarction MI 55 LVEF 55 thrombotic events 55 plus prednisone 55 LMWH 55 carvedilol 55 annualized relapse 55 rHuPH# 55 Cmax 55 Secondary endpoints 55 cardiac toxicity 55 TORISEL 55 glucose lowering 55 tiotropium 55 azacitidine 55 valsartan 55 laboratory abnormalities 55 Lantus R 55 fondaparinux 54 CYPHER ® Stent 54 ziprasidone 54 noninferiority 54 bosentan 54 myocardial ischemia 54 ACE inhibitor 54 verapamil 54 coronary revascularization 54 peginterferon alfa 2a 54 events AEs 54 cardiovascular morbidity 54 myocardial infarctions 54 bivalirudin 54 febuxostat 54 intravenously administered 54 adalimumab 54 dronedarone 54 glimepiride 54 lamotrigine 53 pregabalin 53 mg kg dose 53 clopidogrel 53 hsCRP 53 quetiapine 53 COPAXONE ® 53 levetiracetam 53 olanzapine 53 alendronate 53 myocardial infarction 53 peginterferon 53 composite endpoint 53 ADHF 53 evaluable 53 cardiac dysfunction 53 lacosamide 53 discontinuations 53 cytogenetic response 53 hypercalcemia 53 Eloxatin R 53 Torisel 53 sustained virologic response 53 claudication

Back to home page